ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Convergence

ARP Year in Review: Updates in Advanced Practice, Epidemiology & Rehabilitation

Catherine Kolonko   |  November 12, 2025

Three experts discussed recent notable research of interest to rheumatology professionals across a range of topics.

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD  |  November 12, 2025

Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.

The ACR Revamps RISE Registry into a Productivity & Learning Tool

Mary Beth Nierengarten  |  November 10, 2025

The ACR’s new RISE Registry, set for 2026, will be a modern productivity tool with new analytics, easy EHR connection & robust research data.

ACR Advocacy Update 2025, Federal & State

Mary Beth Nierengarten  |  November 9, 2025

ACR representatives outlined its 2025 legislative priorities, including fixing the MPFS, reforming prior authorization & protecting telehealth reimbursement.

As Understanding of Long COVID Deepens, the Search for Therapies Continues

Thomas R. Collins  |  November 7, 2025

Experts discussed causes of long COVID & potential therapies at this ACR Convergence 2025 session.

No Longer as Vexing: The Role of Somatic Mutations in Rheumatic Diseases

Jason Liebowitz, MD, FACR  |  November 7, 2025

At this ACR Convergence 2025 session, two experts discussed VEXAS & the role that genetic sequencing should play in the practice of a rheumatologist.

Collaboration Is Key to Oral Health in Scleroderma & Sjögren’s Disease

Catherine Kolonko  |  November 7, 2025

At this ACR Convergence 2025 session, experts discussed the oral manifestations of scleroderma & Sjögren’s disease & the importance of dentists & rheumatologists working together.

The Microbiome’s Impact on Rheumatoid Arthritis & Drug Response

Ruth Jessen Hickman, MD  |  November 7, 2025

The gut microbiome may trigger RA & predict methotrexate response. ACR Convergence 2025 experts discuss pathogenesis & drug efficacy.

Differentiating POTS from Other Conditions

Mary Beth Nierengarten  |  November 6, 2025

At a ACR Convergence 2025 session, two experts discussed POTS, the importance of considering dysautonomia when making a differential diagnosis & an interdisciplinary approach to treatment.

The Pros & Cons of AI

Thomas R. Collins  |  November 5, 2025

As the uses for artificial intelligence grow within rheumatology, so do the benefits and the concerns about the technology. In a session at ACR Convergence 2025, two experts discuss the research on both sides of the debate.

  • 1
  • 2
  • 3
  • …
  • 41
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences